Nom du produit:trideuteriomethyl N-[(E)-(1,4-dioxidoquinoxaline-1,4-diium-2-yl)methylideneamino]carbamate
IUPAC Name:3-[(E)-({[(²H₃)methoxycarbonyl]amino}imino)methyl]quinoxaline-1,4-diium-1,4-bis(olate)
- CAS:1185240-06-5
- Formule moléculaire:C11H10N4O4
- Pureté:95%+
- Numéro de catalogue:CM1010181
- Poids moléculaire:265.24
Unité d'emballage |
Stock disponible |
Prix($) |
Quantité |
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:1185240-06-5
- Formule moléculaire:C11H10N4O4
- Point de fusion:-
- Code SMILES:[2H]C([2H])([2H])OC(=O)N\N=C\C1=C[N+]([O-])=C2C=CC=CC2=[N+]1[O-]
- Densité:
- Numéro de catalogue:CM1010181
- Poids moléculaire:265.24
- Point d'ébullition:
- N° Mdl:
- Stockage:
Category Infos
- Quinoxalines
- Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.